Zenas BioPharma, Inc. — Form D

Zenas BioPharma, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-15. The offering totals $183.9M, of which $183.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
HUA O MUDirectorWALTHAM, MA
MARIETTA O WUDirectorWALTHAM, MA
HUA O MUExecutive OfficerWALTHAM, MA
Leon O Moulder, Jr.DirectorExton, PA
Leon O Moulder, Jr.Executive OfficerExton, PA
PATRICK GERALD ENRIGHTDirectorWALTHAM, MA
TOMAS O KISELAKDirectorWALTHAM, MA
PATRICIA JACOB ALLENDirectorWALTHAM, MA
JOSEPH O FARMERExecutive OfficerWALTHAM, MA
JAKE JACOB NUNNDirectorWALTHAM, MA
TIM JACOB XIAODirectorWALTHAM, MA
JENNIFER JACOB FOXExecutive OfficerWALTHAM, MA
JAMES PATRICK BOYLANDirectorWALTHAM, MA
TANYA Z FISCHERExecutive OfficerWALTHAM, MA
JOHN JACOB ORLOFFDirectorWALTHAM, MA
HONGBO O LUDirectorWALTHAM, MA

Other filings by this issuer (1)

FiledFormOfferingSold
2024-05-14D$200.1M$200.1M

More